Robert Mauch Biography and Net Worth

EVP of Cencora

Robert Mauch is the Executive Vice President & Group President of AmerisourceBergen Corporation. In this role, he is focused on creating a best-in-class customer experience and driving growth through strategically relevant, valued-added solutions for providers of pharmaceutical care.

Previously, Mr. Mauch held multiple positions from 2012 to 2017 within AmerisourceBergen Drug Corporation, including Executive Vice President and President, Chief Operating Officer, and Senior Vice President—Operations. One of his key accomplishments during this time was expanding and strengthening AmerisourceBergen’s industry-leading partnership with Walgreens Boots Alliance since it was established in 2013. From 2010 to 2012, Mr. Mauch also held positions as Senior Vice President of Sales and Marketing as well as Vice President for Alternate Care Sales and Marketing for the Drug Corporation.

Mr. Mauch began his more than 30-year career in pharmaceutical care as the founder of Xcenda, which provides health economics, strategic and reimbursement consulting to manufacturers to introduce new pharmaceutical products to the market. He received his Pharm.D. from Mercer University and his Ph.D. in pharmacy administration from the University of South Carolina where he pursued a focus in health economics—specifically, the total cost and benefit of effective pharmaceutical healthcare.

What is Robert P. Mauch's net worth?: The estimated net worth of Robert P. Mauch is at least $13.70 million as of March 3rd, 2025. Mr. Mauch owns 51,070 shares of Cencora stock worth more than $13,702,592 as of March 26th. This net worth approximation does not reflect any other assets that Mr. Mauch may own. Additionally, Mr. Mauch receives a salary of $2,700,000.00 as EVP at Cencora. Learn More about Robert P. Mauch's net worth.
How old is Robert P. Mauch?: Mr. Mauch is currently 57 years old. There are 7 older executives and no younger executives at Cencora. The oldest executive at Cencora is Ms. Gina K. Clark, Executive VP and Chief Communications & Administration Officer, who is 67 years old. Learn More on Robert P. Mauch's age.
What is Robert P. Mauch's salary?: As the EVP of Cencora, Inc., Mr. Mauch earns $2,700,000.00 per year. The highest earning executive at Cencora is Mr. Steven H. Collis, Chairman, President & CEO, who commands a salary of $5,010,000.00 per year. Learn More on Robert P. Mauch's salary.
How do I contact Robert P. Mauch?: The corporate mailing address for Mr. Mauch and other Cencora executives is 1300 MORRIS DRIVE, CHESTERBROOK PA, 19087. Cencora can also be reached via phone at (610) 727-7000 and via email at investorrelations@amerisourcebergen.com. Learn More on Robert P. Mauch's contact information.
Has Robert P. Mauch been buying or selling shares of Cencora?: During the last ninety days, Robert P. Mauch has sold $1,267,350.00 in Cencora stock. Most recently, Robert P. Mauch sold 4,970 shares of the business's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $255.00, for a transaction totalling $1,267,350.00. Following the completion of the sale, the chief executive officer now directly owns 51,070 shares of the company's stock, valued at $13,022,850. Learn More on Robert P. Mauch's trading history.
Who are Cencora's active insiders?: Cencora's insider roster includes Silvana Battaglia (EVP), Elizabeth Campbell (EVP), John Chou (EVP), Gina Clark (EVP), Gina Clark (EVP), Steven Collis (CEO), Leslie Donato (EVP), Leslie Donato (EVP), Jeffrey Finnin (CFO), Juan Font (SVP), Jane Henney, MD (Director), Mark Jones (CAO), Maile Kaiser (SVP), Michael Koehler (Director), Lazarus Krikorian (CAO), Aleksandra Krusko (SVP), Robert Mauch (EVP), Robert Mauch (COO), Derek McCandless (SVP), Henry McGee, III (Director), Steven Smith (CRO), Paul Szurek (CEO), and Brian Warren (SVP). Learn More on Cencora's active insiders.
Are insiders buying or selling shares of Cencora?: During the last year, Cencora insiders bought shares 1 times. They purchased a total of 500 shares worth more than $109,290.00. During the last year, insiders at the sold shares 15 times. They sold a total of 6,513,740 shares worth more than $1,518,606,258.16. The most recent insider tranaction occured on March, 10th when CAO Lazarus Krikorian sold 2,000 shares worth more than $520,120.00. Insiders at Cencora own 10.8% of the company. Learn More about insider trades at Cencora.
Information on this page was last updated on 3/10/2025.

Robert P. Mauch Insider Trading History at Cencora

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/3/2025	Sell	4,970	$255.00	$1,267,350.00	51,070
4/15/2024	Sell	57,564	$235.09	$13,532,720.76	24,412
11/4/2022	Sell	21,802	$160.00	$3,488,320.00	20,197
2/1/2022	Sell	44,492	$137.04	$6,097,183.68
11/2/2021	Sell	41,214	$125.34	$5,165,762.76
1/6/2021	Sell	16,561	$105.06	$1,739,898.66	38,363
12/14/2020	Sell	77,560	$98.02	$7,602,431.20	99,362
8/20/2020	Sell	5,262	$101.72	$535,250.64	28,091
7/20/2020	Sell	5,262	$104.40	$549,352.80	28,091
6/19/2020	Sell	5,262	$102.00	$536,724.00	28,091
5/20/2020	Sell	5,262	$90.00	$473,580.00	28,091
4/20/2020	Sell	5,262	$90.00	$473,580.00	28,091
3/31/2020	Sell	5,263	$90.00	$473,670.00	28,092
5/28/2019	Sell	24,767	$81.16	$2,010,089.72	43,286
6/13/2018	Sell	1,000	$90.00	$90,000.00
4/30/2018	Sell	1,000	$93.28	$93,280.00	13,123
4/17/2018	Sell	1,000	$90.00	$90,000.00	13,123
2/28/2018	Sell	1,000	$97.94	$97,940.00
12/14/2017	Sell	3,000	$90.00	$270,000.00	14,531
2/27/2015	Sell	19,415	$102.79	$1,995,667.85

See Full Table

Robert P. Mauch Buying and Selling Activity at Cencora

Cencora Company Overview

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Today's Range

Now: $269.22

$267.90

$271.66

50 Day Range

MA: $251.80

$237.74

$268.31

2 Week Range

Now: $269.22

$214.77

$271.52

Volume

210,817 shs

Average Volume

1,375,435 shs

Market Capitalization

$52.21 billion

P/E Ratio

38.31

Dividend Yield

0.83%

Beta

0.51

Robert Mauch Biography and Net Worth

What is Robert P. Mauch's net worth?

How old is Robert P. Mauch?

What is Robert P. Mauch's salary?

How do I contact Robert P. Mauch?

Has Robert P. Mauch been buying or selling shares of Cencora?

Who are Cencora's active insiders?

Are insiders buying or selling shares of Cencora?